Z-0588-2021 Class II Terminated
FDA device recall Z-0588-2021 was initiated by Becton Dickinson & Company on Nov 18, 2020 and is designated Class II. Reason for recall: BD has confirmed the presence of blood on the cannulas of the BD PrecisionGlide needles 30G X 1/2" Lot No. 9128897. The possibility of infection may be present if the blood is not noticed prior to use… The recall status is terminated (terminated Feb 15, 2024). Affected quantity: 1,430,000.
Recall details
- Product Type
- Devices
- Report Date
- Dec 23, 2020
- Initiation Date
- Nov 18, 2020
- Termination Date
- Feb 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,430,000
Product description
BD PrecisionGlide Needle 30G x 1/2 (0.3 mm X 13mm) REF 305106 - Product Usage: used for general purpose injection and aspiration of fluids from vials, ampoules and parts of the body below the surface of the skin.
Reason for recall
BD has confirmed the presence of blood on the cannulas of the BD PrecisionGlide needles 30G X 1/2" Lot No. 9128897. The possibility of infection may be present if the blood is not noticed prior to use by the clinician.
Distribution pattern
Worldwide distribution - US Nationwide distribution including in the states of CA, CT, FL, IL, KY, MO, NJ, NY, OH, PA, PR, SC, TN, VA and the countries of Canada, China, Singapore.
Code information
Catalog Ref No.: 305106 Lot No:. 9128897 Expiration Date: 2024-06-30 UDI: 30382903051060 Product Package Size: 100 units per carton
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0588-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026